Drug Test/Screening Collector Training & Certification, Merrill, OR

For

Collection Sites, Medical Facilities, DER's, HR Managers, Safety Managers, Court Personnel, Probation Officers, TPA's

Accredited Drug Testing provides a comprehensive online/web-based Urine Drug Testing Collector Training and Certification course in Merrill, OR for persons required as part of their responsibilities to perform or supervise urine drug testing specimen collections. The collector training program may be completed with or without the required mock collection proficiency assessments. Upon completion of the training program, students will receive a certificate of successful completion of the training course. In Merrill, OR to be qualified/certified as a DOT urine drug test collector, you must satisfactorily complete both the training course and a minimum of 5 error free proficiency mock demonstrations.

Collector Training Only

(800) 221-4291

Training & Proficiency Demonstrations

The Drug Test Collector plays a critical role in the workplace drug screening process. Along with the employer, the testing facility and the Medical Review Officer (MRO), the collector is an essential part of a system developed to ensure drug-free workplaces for the sake of public safety.

As the collector, you are the only individual in the drug-testing process who has direct, face-to-face contact with the employee. You ensure the integrity of the urine specimen and collection process and begin the chain of custody that includes the laboratory; the MRO; the employer; and, possibly, the courts.

This training is a professional-level course that provides the knowledge and skills to qualify Drug Test Collectors to perform U.S. Department of Transportation-regulated drug tests and non-regulated tests. Course participants also have the option of becoming professionally certified after completion of this course. This designation confirms that the collector is committed to the highest standards in the drug and alcohol testing industry.

The Course

This professional-level course meets the regulatory standards of U.S. Department of Transportation (DOT) rule 49 CFR Part 40 and provides a solid foundation for a wide range of testing programs.

Library of terms & resources
Universal skills set
Multiple industries
Lessons
DOT Qualification
Public sector
Short quizzes & final examination
Professional Certification
Private sector
Mock collections
Regulated by local, state and federal authorities
Signature

How to become a DOT Qualified Urine Colletor?

To become qualified as a collector, you must be knowledgeable about Part 40 regulations, the current "DOT Urine Specimen Collection Procedures Guidelines," and DOT agency regulations applicable to the employers for whom you will perform collections, and you must keep current on any changes to these materials. You must also (1) successfully complete a qualification training program and (2) pass a monitored proficiency demonstration, as required by DOT regulations [See 49 CFR Part 40.33 (b-c), effective August 1, 2001]. Please note: there is no "grandfather" clause or waiver from this requirement. A collector's qualifications are not location/collection site specific, and their eligibility will follow them anywhere DOT Agency regulated urine specimens are collected. There is no requirement for qualified collectors to register or to be on any federally-maintained or federally-sponsored list, but they are required to maintain (for Federal inspection) documentation of successful completion of their training and proficiency demonstration requirements.

How to Take the Course

The Drug Test Collector Training involves multiple parts that need to be completed in a specific order to achieve certification.

Before starting the training, the collector must:
- review 49 CFR Part 40 and be familiar with the regulatory language;
- review the DOT Urine Specimen Collection Guidelines;
- review "Instructions for Completing the Federal Drug Testing Custody and Control Form for Urine Specimen Collection"
- watch DOT's 10 Steps to Collection Site Security and Integrity video.
- and download the sample Custody and Control Form. This form guides the entire drug-collection process. Review the document and have it at hand through the entire course. (All required materials are also available in the Reference Library.) NOTE: The 2017 version of the CCF is no longer current. If you intend to use it, you must attach a Memorandum for Record (MFR).
Take the course Pre-Test to show familiarity with the subject matter based on a review of the materials provided.
Complete the lessons of the training along with the required short quizzes.
Take the final exam. A score of at least 90 percent is required.
When you pass the online portion of this training, continue to the Next Steps lesson for instructions on how to set up five mock collections with a live examiner. These must be scheduled within 30 days of course completion and are required for qualification and certification.
Once the mock collections are completed without error, you will be qualified and can perform both federally regulated and non-regulated drug test collections.
To be certified, qualified collectors are asked to sign an agreement promising to adhere to the standards set in the training. The course administrator will then issue a certification form documenting that the collector is both a USDOT Qualified and Professionally Certified Drug Testing Collector. Contact the course administrator for more information.

Collector Training Only

(800) 221-4291

Merrill, OR Drug Testing

Merrill, OR Certified Drug Test Collector Training

Merrill, OR FMCSA Drug Testing

Merrill, OR Drug Test Locations

Merrill, OR Lab and Blood Testing

Merrill, OR STD Testing

Merrill, OR In-Home Drug Testing

Merrill, OR DNA Testing

Local Area Info: Merrill Lynch

Merrill, previously Merrill Lynch, is an American investing and wealth management division under the auspices of Bank of America. Along with BofA Securities, the investment banking arm, both firms engage in prime brokerage and security dealings. The firm is headquartered in New York City, and occupies the entire 34 stories of 250 Vesey Street, part of the Brookfield Place complex, in Manhattan. Merrill employs over 15,000 financial advisors and manages $2.2 trillion in client assets.

The firm has its origins in Merrill Lynch & Co., Inc. which, prior to 2009, was publicly owned and traded on the New York Stock Exchange under the ticker symbol MER. Merrill Lynch & Co. agreed to be acquired by Bank of America on September 14, 2008, at the height of the 2008 Financial Crisis. The acquisition was completed in January 2009 and Merrill Lynch & Co., Inc. was merged into Bank of America Corporation in October 2013, with certain Bank of America subsidiaries continue to carry the Merrill Lynch name, including the broker-dealer Merrill Lynch, Pierce, Fenner & Smith. In 2019, Bank of America rebranded the unit to "Merrill."

Significant losses were attributed to the drop in value of its large and unhedged mortgage portfolio in the form of collateralized debt obligations. Trading partners' loss of confidence in Merrill Lynch's solvency and ability to refinance short-term debt ultimately led to its sale.[dead link] During the week of September 8, 2008, Lehman Brothers came under severe liquidity pressures, with its survival in question. If Lehman Brothers failed, investors were afraid that the contagion could spread to the other surviving investment banks. On Sunday, September 14, 2008, Bank of America announced it was in talks to purchase Merrill Lynch for $38.25 billion in stock. The Wall Street Journal reported later that day that Merrill Lynch was sold to Bank of America for 0.8595 share of Bank of America common stock for each Merrill Lynch common share, or about US$50 billion or $29 per share. This price represented a 70.1% premium over the September 12 closing price or a 38% premium over Merrill's book value of $21 a share, but that also meant a discount of 61% from its September 2007 price.